Cas and NEDD9 Contribute to Tumor Progression through Dynamic Regulation of the Cytoskeleton

Genes and Cancer

Volumn 3, Issue 5-6, 2012, Pages 371-381

  Guerrero, Michael S ^a   Parsons, J Thomas ^a   Bouton, Amy H ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Cas; FAK; mechanosensor; NEDD9; Rac1; Src

Indexed keywords

ADAPTOR PROTEIN; CELLULAR APOPTOSIS SUSCEPTIBILITY PROTEIN; CRK ASSOCIATED SUBSTRATE PROTEIN; DOCETAXEL; GROWTH FACTOR; LIPOSOME; PROTEIN NEDD9; SMALL INTERFERING RNA; TAXANE DERIVATIVE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BCAR1 GENE; CANCER CONTROL; CANCER GROWTH; CANCER PROGNOSIS; CANCER RESISTANCE; CANCER SURVIVAL; CARCINOGENESIS; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; CYTOSKELETON; DIAGNOSTIC VALUE; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; GENOMIC INSTABILITY; HUMAN; MECHANOTRANSDUCTION; METASTASIS; MOLECULAR DYNAMICS; NANOPHARMACEUTICS; NONHUMAN; OVARY TUMOR; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SURVIVAL TIME; TUMOR GROWTH; TUMOR VASCULARIZATION;

EID: 84875486797     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: 10.1177/1947601912458585     Document Type: Article

References (92)

1. Schlaepfer DD,Broome MA,Hunter T.Fibronectin-stimulated signaling from a focal adhesion kinase-c-Src complex: involvement of the Grb2, p130cas, and Nck adaptor proteins.Mol Cell Biol. 1997;17:1702-13.
2. Ruest PJ,Shin NY,Polte TR,Zhang X,Hanks SK.Mechanisms of CAS substrate domain tyrosine phosphorylation by FAK and Src.Mol Cell Biol. 2001;21:7641-52.
3. Mitra SK,Schlaepfer DD.Integrin-regulated FAK-Src signaling in normal and cancer cells.Curr Opin Cell Biol. 2006;18:516-23.
4. Honda H,Oda H,Nakamoto T.Cardiovascular anomaly, impaired actin bundling and resistance to Src-induced transformation in mice lacking p130Cas. Nat Genet.et al. 1998;19:361-5.
5. Cabodi S,del Pilar Camacho-Leal M,Di Stefano P,Defilippi P.Integrin signalling adaptors: not only figurants in the cancer story.Nat Rev Cancer. 2010;10:858-70.
6. Bouton AH,Riggins RB,Bruce-Staskal PJ.Functions of the adapter protein Cas: signal convergence and the determination of cellular responses.Oncogene. 2001;20:6448-58.
7. Tikhmyanova N,Little JL,Golemis EA.CAS proteins in normal and pathological cell growth control.Cell Mol Life Sci. 2010;67:1025-48.
8. Sakai R,Iwamatsu A,Hirano N, et al.A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner.EMBO J. 1994;13:3748-56.
9. Cabodi S,Tinnirello A,Di Stefano P, et al.p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. Cancer Res. 2006;66:4672-80.
10. Dorssers LC,Grebenchtchikov N,Brinkman A, et al.The prognostic value of BCAR1 in patients with primary breast cancer. Clin Cancer Res. 2004;10:6194-202.
11. Nick AM,Stone RL,Armaiz-Pena G, et al.Silencing of p130cas in ovarian carcinoma: a novel mechanism for tumor cell death.J Natl Cancer Inst. 2011;103:1596-612.
12. Fromont G,Rozet F,Cathelineau X, et al.BCAR1 expression improves prediction of biochemical reccurence after radical prostatectomy.Prostate. 2012;72:1359-65.
13. Huang W,Deng B,Wang RW, et al.BCAR1 protein plays important roles in carcinogenesis and predicts poor prognosis in non-small-cell lung cancer.PLoS One. 2012;7:e36124.
14. O'Neill GM,Fashena SJ,Golemis EA.Integrin signalling: a new Cas(t) of characters enters the stage.Trends Cell Biol. 2000;10:111-9.
15. Burnham MR,Bruce-Staskal PJ,Harte MT, et al.Regulation of c-SRC activity and function by the adapter protein CAS.Mol Cell Biol. 2000;20:5865-78.
16. Nasertorabi F,Tars K,Becherer K, et al.Molecular basis for regulation of Src by the docking protein p130Cas.J Mol Recognit. 2006;19:30-8.
17. Brabek J,Constancio SS,Shin NY,Pozzi A,Weaver AM,Hanks SK.CAS promotes invasiveness of Src-transformed cells.Oncogene. 2004;23:7406-15.
18. Vuori K,Hirai H,Aizawa S,Ruoslahti E.Introduction of p130cas signaling complex formation upon integrin-mediated cell adhesion: a role for Src family kinases.Mol Cell Biol. 1996;16:2606-13.
19. Kiyokawa E,Hashimoto Y,Kurata T,Sugimura H,Matsuda M.Evidence that DOCK180 up-regulates signals from the CrkII-p130(Cas) complex.J Biol Chem. 1998;273:24479-84.
20. Klemke RL,Leng J,Molander R,Brooks PC,Vuori K,Cheresh DA.CAS/Crk coupling serves as a "molecular switch" for induction of cell migration.J Cell Biol. 1998;140:961-72.
21. Tamada M,Sheetz MP,Sawada Y.Activation of a signaling cascade by cytoskeleton stretch.Dev Cell. 2004;7:709-18.
22. Hattori M,Minato N.Rap1 GTPase: functions, regulation, and malignancy.J Biochem. 2003;134:479-84.
23. Vega FM,Ridley AJ.Rho GTPases in cancer cell biology.FEBS Lett. 2008;582:2093-101.
24. Izumchenko E,Singh MK,Plotnikova OV, et al.NEDD9 promotes oncogenic signaling in mammary tumor development.Cancer Res. 2009;69:7198-206.
25. Wendt MK,Smith JA,Schiemann WP.p130Cas is required for mammary tumor growth and transforming growth factor-beta-mediated metastasis through regulation of Smad2/3 activity.J Biol Chem. 2009;284:34145-56.
26. Mitra SK,Mikolon D,Molina JE, et al.Intrinsic FAK activity and Y925 phosphorylation facilitate an angiogenic switch in tumors.Oncogene. 2006;25:5969-84.
27. Kim W,Seok Kang Y,Soo Kim J,Shin NY,Hanks SK,Song WK.The integrin-coupled signaling adaptor p130Cas suppresses Smad3 function in transforming growth factor-beta signaling.Mol Biol Cell. 2008;19:2135-46.
28. Ambrogio C,Voena C,Manazza AD, et al.p130Cas mediates the transforming properties of the anaplastic lymphoma kinase.Blood. 2005;106:3907-16.
29. Saltel F,Daubon T,Juin A,Ganuza IE,Veillat V,Genot E.Invadosomes: intriguing structures with promise.Eur J Cell Biol. 2011;90:100-7.
30. Pugacheva EN,Golemis EA.The focal adhesion scaffolding protein HEF1 regulates activation of the Aurora-A and Nek2 kinases at the centrosome.Nat Cell Biol. 2005;7:937-46.
31. Pugacheva EN,Golemis EA.HEF1-aurora A interactions: points of dialog between the cell cycle and cell attachment signaling networks.Cell Cycle. 2006;5:384-91.
32. Hall A.The cytoskeleton and cancer.Cancer Metastasis Rev. 2009;28:5-14.
33. Dadke D,Jarnik M,Pugacheva EN,Singh MK,Golemis EA.Deregulation of HEF1 impairs M-phase progression by disrupting the RhoA activation cycle.Mol Biol Cell. 2006;17:1204-17.
34. Yamakita Y,Totsukawa G,Yamashiro S, et al.Dissociation of FAK/p130(CAS)/c-Src complex during mitosis: role of mitosis-specific serine phosphorylation of FAK.J Cell Biol. 1999;144:315-24.
35. Ma A,Richardson A,Schaefer EM,Parsons JT.Serine phosphorylation of focal adhesion kinase in interphase and mitosis: a possible role in modulating binding to p130(Cas).Mol Biol Cell. 2001;12:1-12.
36. Greaves M,Maley CC.Clonal evolution in cancer.Nature. 2012;481:306-13.
37. Ojaniemi M,Vuori K.Epidermal growth factor modulates tyrosine phosphorylation of p130Cas. Involvement of phosphatidylinositol 3′-kinase and actin cytoskeleton.J Biol Chem. 1997;272:25993-8.
38. Avraham HK,Lee TH,Koh Y, et al.Vascular endothelial growth factor regulates focal adhesion assembly in human brain microvascular endothelial cells through activation of the focal adhesion kinase and related adhesion focal tyrosine kinase.J Biol Chem. 2003;278:36661-8.
39. Lucas JT,Salimath BP,Slomiany MG,Rosenzweig SA.Regulation of invasive behavior by vascular endothelial growth factor is HEF1-dependent.Oncogene. 2010;29:4449-59.
40. Zheng M,McKeown-Longo PJ.Regulation of HEF1 expression and phosphorylation by TGF-beta 1 and cell adhesion.J Biol Chem. 2002;277:39599-608.
41. Fagerstrom S,Pahlman S,Nanberg E.Protein kinase C-dependent tyrosine phosphorylation of p130cas in differentiating neuroblastoma cells.J Biol Chem. 1998;273:2336-43.
42. Evans IM,Yamaji M,Britton G, et al.Neuropilin-1 signaling through p130Cas tyrosine phosphorylation is essential for growth factor-dependent migration of glioma and endothelial cells.Mol Cell Biol. 2011;31:1174-85.
43. Casamassima A,Rozengurt E.Tyrosine phosphorylation of p130(cas) by bombesin, lysophosphatidic acid, phorbol esters, and platelet-derived growth factor: signaling pathways and formation of a p130(cas)-Crk complex.J Biol Chem. 1997;272:9363-70.
44. Ridley AJ,Hall A.The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors.Cell. 1992;70:389-99.
45. Cho SY,Klemke RL.Extracellular-regulated kinase activation and CAS/Crk coupling regulate cell migration and suppress apoptosis during invasion of the extracellular matrix.J Cell Biol. 2000;149:223-36.
46. Oktay M,Wary KK,Dans M,Birge RB,Giancotti FG.Integrin-mediated activation of focal adhesion kinase is required for signaling to Jun NH2-terminal kinase and progression through the G1 phase of the cell cycle.J Cell Biol. 1999;145:1461-9.
47. Hanahan D,Weinberg RA.Hallmarks of cancer: the next generation.Cell. 2011;144:646-74.
48. Lee CY,Bautch VL.Ups and downs of guided vessel sprouting: the role of polarity.Physiology (Bethesda). 2011;26:326-33.
49. Funasaka K,Ito S,Hasegawa H, et al.Cas utilizes Nck2 to activate Cdc42 and regulate cell polarization during cell migration in response to wound healing.FEBS J. 2010;277:3502-13.
50. Tang H,Hao Q,Fitzgerald T,Sasaki T,Landon EJ,Inagami T.Pyk2/CAKbeta tyrosine kinase activity-mediated angiogenesis of pulmonary vascular endothelial cells.J Biol Chem. 2002;277:5441-7.
51. Hsia DA,Mitra SK,Hauck CR, et al.Differential regulation of cell motility and invasion by FAK.J Cell Biol. 2003;160:753-67.
52. Wang Y,McNiven MA.Invasive matrix degradation at focal adhesions occurs via protease recruitment by a FAK-p130Cas complex.J Cell Biol. 2012;196:375-85.
53. Paszek MJ,Zahir N,Johnson KR, et al.Tensional homeostasis and the malignant phenotype.Cancer Cell. 2005;8:241-54.
54. Alexander NR,Branch KM,Parekh A, et al.Extracellular matrix rigidity promotes invadopodia activity.Curr Biol. 2008;18:1295-9.
55. Levental KR,Yu H,Kass L, et al.Matrix crosslinking forces tumor progression by enhancing integrin signaling.Cell. 2009;139:891-906.
56. Tilghman RW,Cowan CR,Mih JD, et al.Matrix rigidity regulates cancer cell growth and cellular phenotype.PLoS One. 2010;5:e12905.
57. Kostic A,Sheetz MP.Fibronectin rigidity response through Fyn and p130Cas recruitment to the leading edge.Mol Biol Cell. 2006;17:2684-95.
58. Sawada Y,Tamada M,Dubin-Thaler BJ, et al.Force sensing by mechanical extension of the Src family kinase substrate p130Cas.Cell. 2006;127:1015-26.
59. Baker AM,Bird D,Lang G,Cox TR,Erler JT.Lysyl oxidase enzymatic function increases stiffness to drive colorectal cancer progression through FAK.Oncogene. 2012;:.
60. Payne SL,Fogelgren B,Hess AR, et al.Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism.Cancer Res. 2005;65:11429-36.
61. Payne SL,Hendrix MJ,Kirschmann DA.Lysyl oxidase regulates actin filament formation through the p130(Cas)/Crk/DOCK180 signaling complex.J Cell Biochem. 2006;98:827-37.
62. Huang M,Anand S,Murphy EA, et al.EGFR-dependent pancreatic carcinoma cell metastasis through Rap1 activation.Oncogene. 2012;31:2783-93.
63. Kim M,Gans JD,Nogueira C, et al.Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene.Cell. 2006;125:1269-81.
64. Thiery JP,Sleeman JP.Complex networks orchestrate epithelial-mesenchymal transitions.Nat Rev Mol Cell Biol. 2006;7:131-42.
65. Tikhmyanova N,Golemis EA.NEDD9 and BCAR1 negatively regulate E-cadherin membrane localization, and promote E-cadherin degradation.PLoS One. 2011;6:e22102.
66. Kong C,Wang C,Wang L, et al.NEDD9 is a positive regulator of epithelial-mesenchymal transition and promotes invasion in aggressive breast cancer.PLoS One. 2011;6:e22666.
67. Li Y,Bavarva JH,Wang Z, et al.HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progression.Oncogene. 2011;30:2633-43.
68. Reinhold MI,Kapadia RM,Liao Z,Naski MC.The Wnt-inducible transcription factor Twist1 inhibits chondrogenesis.J Biol Chem. 2006;281:1381-8.
69. Yang WH,Lan HY,Huang CH, et al.RAC1 activation mediates Twist1-induced cancer cell migration.Nat Cell Biol. 2012;14:366-74.
70. Ahn J,Sanz-Moreno V,Marshall CJ.The metastasis gene NEDD9 product acts through integrin beta3 and Src to promote mesenchymal motility and inhibit amoeboid motility.J Cell Sci. 2012;125:1814-26.
71. Tornillo G,Bisaro B,Camacho-Leal Mdel P, et al.p130Cas promotes invasiveness of three-dimensional ErbB2-transformed mammary acinar structures by enhanced activation of mTOR/p70S6K and Rac1.Eur J Cell Biol. 2011;90:237-48.
72. Cary LA,Han DC,Polte TR,Hanks SK,Guan JL.Identification of p130Cas as a mediator of focal adhesion kinase-promoted cell migration.J Cell Biol. 1998;140:211-21.
73. Cheresh DA,Leng J,Klemke RL.Regulation of cell contraction and membrane ruffling by distinct signals in migratory cells.J Cell Biol. 1999;146:1107-16.
74. Cho SY,Klemke RL.Purification of pseudopodia from polarized cells reveals redistribution and activation of Rac through assembly of a CAS/Crk scaffold.J Cell Biol. 2002;156:725-36.
75. Sanz-Moreno V,Gadea G,Ahn J, et al.Rac activation and inactivation control plasticity of tumor cell movement.Cell. 2008;135:510-23.
76. Abassi YA,Rehn M,Ekman N,Alitalo K,Vuori K.p130Cas Couples the tyrosine kinase Bmx/Etk with regulation of the actin cytoskeleton and cell migration.J Biol Chem. 2003;278:35636-43.
77. Yi J,Kloeker S,Jensen CC, et al.Members of the Zyxin family of LIM proteins interact with members of the p130Cas family of signal transducers.J Biol Chem. 2002;277:9580-9.
78. Hoffman LM,Jensen CC,Chaturvedi A,Yoshigi M,Beckerle MC.Stretch-induced actin remodeling requires targeting of zyxin to stress fibers and recruitment of actin regulators.Mol Biol Cell. 2012;23:1846-59.
79. Pratt SJ,Epple H,Ward M,Feng Y,Braga VM,Longmore GD.The LIM protein Ajuba influences p130Cas localization and Rac1 activity during cell migration.J Cell Biol. 2005;168:813-24.
80. Fraley SI,Feng Y,Giri A,Longmore GD,Wirtz D.Dimensional and temporal controls of three-dimensional cell migration by zyxin and binding partners.Nat Commun. 2012;3:719.
81. Fidler IJ.The pathogenesis of cancer metastasis: the "seed and soil" hypothesis revisited.Nat Rev Cancer. 2003;3:453-8.
82. Wei L,Yang Y,Zhang X,Yu Q.Anchorage-independent phosphorylation of p130(Cas) protects lung adenocarcinoma cells from anoikis.J Cell Biochem. 2002;87:439-49.
83. Okuda M,Takahashi M,Suero J, et al.Shear stress stimulation of p130(cas) tyrosine phosphorylation requires calcium-dependent c-Src activation.J Biol Chem. 1999;274:26803-9.
84. Thamilselvan V,Basson MD.Pressure activates colon cancer cell adhesion by inside-out focal adhesion complex and actin cytoskeletal signaling.Gastroenterology. 2004;126:8-18.
85. Fennewald SM,Kantara C,Sastry SK,Resto VA.Laminin interaction with head and neck cancer cells under low fluid shear conditions leads to integrin activation and binding.J Biol Chem. 2012;287:21058-66.
86. Nojima Y,Morino N,Mimura T, et al.Integrin-mediated cell adhesion promotes tyrosine phosphorylation of p130Cas, a Src homology 3-containing molecule having multiple Src homology 2-binding motifs.J Biol Chem. 1995;270:15398-402.
87. Zaidel-Bar R,Kam Z,Geiger B.Polarized downregulation of the paxillin-p130CAS-Rac1 pathway induced by shear flow.J Cell Sci. 2005;118:3997-4007.
88. Dorssers LC,van Agthoven T,Dekker A,van Agthoven TL,Kok EM.Induction of antiestrogen resistance in human breast cancer cells by random insertional mutagenesis using defective retroviruses: identification of bcar-1, a common integration site.Mol Endocrinol. 1993;7:870-8.
89. Brinkman A,van der Flier S,Kok EM,Dorssers LC.BCAR1, a human homologue of the adapter protein p130Cas, and antiestrogen resistance in breast cancer cells.J Natl Cancer Inst. 2000;92:112-20.
90. Riggins RB,Thomas KS,Ta HQ, et al.Physical and functional interactions between Cas and c-Src induce tamoxifen resistance of breast cancer cells through pathways involving epidermal growth factor receptor and signal transducer and activator of transcription 5b.Cancer Res. 2006;66:7007-15.
91. Ta HQ,Thomas KS,Schrecengost RS,Bouton AH.A novel association between p130Cas and resistance to the chemotherapeutic drug adriamycin in human breast cancer cells.Cancer Res. 2008;68:8796-804.
92. Thao le B,Vu HA,Yasuda K, et al.Cas-L was overexpressed in imatinib-resistant gastrointestinal stromal tumor cells.Cancer Biol Ther. 2009;8:683-8.